Consolidated Statements of Cash Flows	3 Months Ended	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)
OPERATING ACTIVITIES
Net (loss) income	$ 1,404,000	$ (6,703,000)	$ 11,480,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Gain on sales	(679,000)	(679,000)	(2,942,000)
Impairment charges		7,607,000
Straight-line rents and expenses, net		1,304,000	(298,000)
Provision for doubtful accounts		1,010,000	233,000
Depreciation and amortization	10,035,000	38,208,000	31,022,000
Amortization of intangible lease liabilities, net	(299,000)	(1,065,000)	(2,212,000)
Expense relating to share-based compensation, net		2,753,000	3,078,000
Amortization of deferred financing costs		969,000	967,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:
Rents and other receivables		(3,381,000)	(2,068,000)
Prepaid expenses and other		(12,280,000)	(5,788,000)
Accounts payable and accrued liabilities		(1,574,000)	2,922,000
Net cash provided by operating activities		26,169,000	36,394,000
INVESTING ACTIVITIES
Expenditures for real estate improvements		(29,815,000)	(23,816,000)
Net proceeds from sales of real estate		5,013,000	18,651,000
Acquisition of real estate			(9,083,000)
Net cash (used in) investing activities		(24,802,000)	(14,248,000)
FINANCING ACTIVITIES
Repayments under revolving credit facility		(83,100,000)	(16,000,000)
Advances under revolving credit facility		98,000,000	23,000,000
Mortgage repayments		(797,000)	(766,000)
Payments of debt financing costs		(305,000)
Noncontrolling interests:
Distributions to limited partners		(37,000)	(84,000)
Redemption of OP Units			(43,000)
Common stock sales less issuance expenses, net		11,000	18,000
Common stock repurchases			(6,844,000)
Preferred stock dividends		(8,064,000)	(8,064,000)
Distributions to common shareholders		(6,254,000)	(13,357,000)
Net cash (used in) financing activities		(546,000)	(22,140,000)
Net increase in cash, cash equivalents and restricted cash		821,000	6,000
Cash, cash equivalents and restricted cash at beginning of year		2,747,000	1,977,000
Cash, cash equivalents and restricted cash at end of period	3,568,000	3,568,000	1,983,000
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	3,568,000	3,568,000	1,983,000
Cash, cash equivalents and restricted cash at end of period	$ 3,568,000	$ 3,568,000	$ 1,983,000